Nov 2, 2015 Cellectar Biosciences Provides Phospholipid Drug Conjugate (PDC) Platform Development Update Learn More
Oct 1, 2015 Cellectar Biosciences Awarded $2.3M National Cancer Institute Fast-Track SBIR Grant to Advance Phospholipid Drug Conjugate (PDC) Delivery Platform Learn More